omeprazole has been researched along with Day Blindness in 5 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Piñero Rodríguez, AM | 1 |
| Alvarez López, A | 1 |
| Nadal Reus, J | 1 |
| Creutzfeldt, WC | 1 |
| Blum, AL | 1 |
| Schönhöfer, PS | 2 |
| Werner, B | 1 |
| Tröger, U | 1 |
| Kohno, M | 1 |
| Yamada, M | 1 |
| Okumura, T | 1 |
| Hori, K | 1 |
| Hoshino, U | 1 |
| Yoshimura, T | 1 |
| Lutz, M | 1 |
| Schwab, M | 1 |
| Griese, EU | 1 |
| Marx, C | 1 |
| Müller-Oerlinghausen, B | 1 |
| Meisner, C | 1 |
| Gleiter, CH | 1 |
| Eichelbaum, M | 1 |
| Mörike, K | 1 |
1 review available for omeprazole and Day Blindness
| Article | Year |
|---|---|
[Two cases of ocular damage associated with proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Female; Humans; Lansopra | 2000 |
4 other studies available for omeprazole and Day Blindness
| Article | Year |
|---|---|
[Atypical manifestations of acute posterior placoid pigment epitheliopathy].
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Cysts; Drug Therapy, Combination; Fluorescein Angiog | 2010 |
Safety of omeprazole.
Topics: Administration, Oral; Consumer Product Safety; Humans; Injections, Intravenous; Omeprazole; Respirat | 1994 |
Ocular damage associated with proton pump inhibitors.
Topics: Anti-Ulcer Agents; Female; Humans; Male; Middle Aged; Omeprazole; Optic Neuropathy, Ischemic; Papill | 1997 |
Visual disorders associated with omeprazole and their relation to CYP2C19 polymorphism.
Topics: Adult; Aged; Aged, 80 and over; Alleles; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Cytochrom | 2002 |